cryptotanshinone has been researched along with Prostatic Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Cui, K; Deng, B; Lin, D; Luo, C; Wei, P; Wu, X; Zhang, M | 1 |
1 other study(ies) available for cryptotanshinone and Prostatic Hyperplasia
| Article | Year |
|---|---|
Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR/STAT3 axis to ameliorate benign prostatic hyperplasia progression.
Topics: Animals; Apoptosis; Cell Proliferation; Collagen; ErbB Receptors; Fibrosis; Humans; Male; Prostatic Hyperplasia; Quality of Life; Rats; STAT3 Transcription Factor | 2023 |